Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker.

Bakker EM, Borsboom GJ, van der Wiel-Kooij EC, Caudri D, Rosenfeld M, Tiddens HA.

Pediatr Pulmonol. 2013 Nov;48(11):1081-8. doi: 10.1002/ppul.22777. Epub 2013 Feb 8.

PMID:
23401260
2.

Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.

Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A.

Thorax. 2008 Feb;63(2):129-34. Epub 2007 Aug 3.

PMID:
17675316
3.

Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?

Lukic KZ, Coates AL.

Pediatr Pulmonol. 2015 Sep;50(9):863-8. doi: 10.1002/ppul.23234. Epub 2015 Jun 16.

PMID:
26079395
4.

Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.

Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW.

Eur Respir J. 2014 Apr;43(4):1051-8. doi: 10.1183/09031936.00128113. Epub 2013 Sep 26.

5.

Spirometry in early childhood in cystic fibrosis patients.

Vilozni D, Bentur L, Efrati O, Minuskin T, Barak A, Szeinberg A, Blau H, Picard E, Kerem E, Yahav Y, Augarten A.

Chest. 2007 Feb;131(2):356-61.

PMID:
17296633
6.

Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.

Bakker EM, Volpi S, Salonini E, Müllinger B, Kroneberg P, Bakker M, Hop WC, Assael BM, Tiddens HA.

Pediatr Pulmonol. 2014 Feb;49(2):154-61. doi: 10.1002/ppul.22800. Epub 2013 Jul 3.

PMID:
23913868
7.

Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European Cystic Fibrosis Patient Registry, 2007-2009.

VanDevanter DR, Pasta DJ.

J Cyst Fibros. 2013 Dec;12(6):786-9. doi: 10.1016/j.jcf.2013.04.005. Epub 2013 Apr 28.

8.

Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012.

VanDevanter DR, Pasta DJ, Konstan MW.

J Pediatr. 2014 Dec;165(6):1091-1097.e2. doi: 10.1016/j.jpeds.2014.06.061. Epub 2014 Aug 16.

9.

Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.

Rosenfeld M, VanDevanter DR, Ren CL, Elkin EP, Pasta DJ, Konstan MW, Morgan WJ; Investigators of Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2015 Sep;50(9):856-62. doi: 10.1002/ppul.23227. Epub 2015 Jun 18.

PMID:
26086901
10.

Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients.

Ribeiro MÂ, Silva MT, Ribeiro JD, Moreira MM, Almeida CC, Almeida-Junior AA, Ribeiro AF, Pereira MC, Hessel G, Paschoal IA.

J Pediatr (Rio J). 2012 Nov-Dec;88(6):509-17. doi: doi:10.2223/JPED.2233.

11.

The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.

Sokol G, Vilozni D, Hakimi R, Lavie M, Sarouk I, Bat-El Bar, Dagan A, Ofek M, Efrati O.

Respir Care. 2015 Dec;60(12):1819-25. doi: 10.4187/respcare.04008. Epub 2015 Sep 15.

12.

Influence of thoracic spine postural disorders on cardiorespiratory parameters in children and adolescents with cystic fibrosis.

Okuro RT, Côrrea EP, Conti PB, Ribeiro JD, Ribeiro MA, Schivinski CI.

J Pediatr (Rio J). 2012 Jul;88(4):310-6. doi: doi:10.2223/JPED.2206.

13.

Growth failure in cystic fibrosis.

McNaughton SA, Stormont DA, Shepherd RW, Francis PW, Dean B.

J Paediatr Child Health. 1999 Feb;35(1):86-92.

PMID:
10234643
14.
15.

Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.

Lin SP, Shih SC, Chuang CK, Lee KS, Chen MR, Niu DM, Chiu PC, Lin SJ, Lin HY.

Pediatr Pulmonol. 2014 Mar;49(3):277-84. doi: 10.1002/ppul.22774. Epub 2013 Feb 8.

PMID:
23401495
16.

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Lechtzin N, West N, Allgood S, Wilhelm E, Khan U, Mayer-Hamblett N, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ Jr, Goss CH.

Contemp Clin Trials. 2013 Nov;36(2):460-9. doi: 10.1016/j.cct.2013.09.004. Epub 2013 Sep 19.

17.

Cough characteristics and FVC maneuver in cystic fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Efrati O.

Respir Care. 2014 Dec;59(12):1912-7. doi: 10.4187/respcare.03290. Epub 2014 Sep 23.

18.

Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis.

Ranganathan SC, Bush A, Dezateux C, Carr SB, Hoo AF, Lum S, Madge S, Price J, Stroobant J, Wade A, Wallis C, Wyatt H, Stocks J.

Am J Respir Crit Care Med. 2002 Nov 15;166(10):1350-7.

PMID:
12421744
19.

Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.

Aurora P, Gustafsson P, Bush A, Lindblad A, Oliver C, Wallis CE, Stocks J.

Thorax. 2004 Dec;59(12):1068-73.

20.

Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.

Nickerson BG, Lemen RJ, Gerdes CB, Wegmann MJ, Robertson G.

Am Rev Respir Dis. 1980 Dec;122(6):859-66.

PMID:
7458059

Supplemental Content

Support Center